Molecular cell · 2025
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Słabicki Mikołaj, Park Jiho, Nowak Radosław P, Roy Burman Shourya S, Pellman Jesse, Zou Charles, Razumkov Hlib, Carreiro Jeannie, Rastogi Simran, Goldstein Anna, Nagiec Marek M, Donovan Katherine A, Che Jianwei, Hunkeler Moritz, Geng Qixiang, Hsu Chi-Lin, Lakshminarayan Megha, Shu Chelsea, Zon Rebecca L, Kozicka Zuzanna, Park Paul M C, Tsai Jonathan M, Yoon Hojong, Jones Lyn H, Sperling Adam S, Gray Nathanael S, Fischer Eric S, Ebert Benjamin L
Аннотация
Glutarimide analogs, such as thalidomide, redirect the E3 ubiquitin ligase CRL4CRBN to induce degradation of certain zinc finger (ZF) proteins. Although the core structural motif recognized by CRBN has been characterized, it does not fully explain substrate specificity. To explore the role of residues adjacent to this core motif, we constructed a comprehensive ZF reporter library of 9,097 reporters derived from 1,655 human ZF proteins and conducted a library-on-library screen with 29 glutarimide analogs to identify compounds that collectively degrade 38 ZF reporters. Cryo-electron microscopy and crystal structures of ZFs in complex with CRBN revealed the importance of interactions beyond the core ZF degron. We used systematic mutagenesis of ZFs and CRBN to identify modes of neosubstrate recruitment requiring distinct amino acids. Finally, we found subtle chemical variations in glutarimide analogs that alter target scope and selectivity, thus providing a roadmap for their rational design.